National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 1 of 1 Research Studies DisplayedPowers C, Gabriel MH, Encinosa W
AHRQ Author: Encinosa W
Meaningful use stage 2 e-prescribing threshold and adverse drug events in the Medicare Part D population with diabetes.
The authors investigated whether physicians who meet the meaningful use stage 2 threshold for e-prescribing (50 percent of prescriptions e-prescribed) have lower rates of ADEs among their diabetic patients. They found that physician e-prescribing to Medicare beneficiaries was associated with reduced risk of ADEs among their diabetes patients, as were several prescriber and panel characteristics.
AHRQ-authored
Citation: Powers C, Gabriel MH, Encinosa W .
Meaningful use stage 2 e-prescribing threshold and adverse drug events in the Medicare Part D population with diabetes.
J Am Med Inform Assoc 2015 Sep;22(5):1094-8. doi: 10.1093/jamia/ocv036..
Keywords: Electronic Prescribing (E-Prescribing), Diabetes, Medication, Patient Safety